Author

B. Maru

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Assay:clinical cohort / trial· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Messikommer· 1 shared A. Theocharides· 1 shared K. Seipel· 1 shared M. McKeague· 1 shared N. W. Luedtke· 1 shared P. J. M. Valk· 1 shared T. Pabst· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Messikommer

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer Prognosis According to Parthanatos Features

A. Messikommer, B. Maru, K. Seipel, P. J. M. Valk, A. Theocharides, T. Pabst, M. McKeague, N. W. Luedtke

This study shows that parthanatos, a PARP-1-mediated cell death pathway, is associated with improved survival in AML patients treated with cytarabine and anthracycline.

bioRxiv · May 24, 2021 · PreprintCancer Biology